Cited In for PMID: 18678846

Year	Number of Results
2008	1
2009	10
2010	5
2011	13
2012	9
2013	10
2014	7
2015	4
2016	6
2017	9
2018	6
2019	7
2020	1
2021	5
2022	4
2023	6
2024	0

1

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force. Lin K, et al. Ann Intern Med. 2008 Aug 5;149(3):192-9. doi: 10.7326/0003-4819-149-3-200808050-00009. Ann Intern Med. 2008. PMID: 18678846 Free article. Review.

2

⁶⁸Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone.

Yang J, Li J, Xiao L, Zhou M, Fang Z, Cai Y, Tang Y, Hu S. Yang J, et al. Cancer Imaging. 2023 Sep 4;23(1):81. doi: 10.1186/s40644-023-00562-x. Cancer Imaging. 2023. PMID: 37667341 Free PMC article.

3

Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers.

Rao Bommi J, Kummari S, Lakavath K, Sukumaran RA, Panicker LR, Marty JL, Yugender Goud K. Rao Bommi J, et al. Biosensors (Basel). 2023 Mar 18;13(3):398. doi: 10.3390/bios13030398. Biosensors (Basel). 2023. PMID: 36979610 Free PMC article. Review.

4

Liquid biopsies: the future of cancer early detection.

Connal S, Cameron JM, Sala A, Brennan PM, Palmer DS, Palmer JD, Perlow H, Baker MJ. Connal S, et al. J Transl Med. 2023 Feb 11;21(1):118. doi: 10.1186/s12967-023-03960-8. J Transl Med. 2023. PMID: 36774504 Free PMC article. Review.

5

PI-RADS^AI: introducing a new human-in-the-loop AI model for prostate cancer diagnosis based on MRI.

Yu R, Jiang KW, Bao J, Hou Y, Yi Y, Wu D, Song Y, Hu CH, Yang G, Zhang YD. Yu R, et al. Br J Cancer. 2023 Apr;128(6):1019-1029. doi: 10.1038/s41416-022-02137-2. Epub 2023 Jan 4. Br J Cancer. 2023. PMID: 36599915 Free PMC article.

6

Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia.

Ge Y, Xu B, Cai H, Jing W, Ouyang Q, Yuan Q, Li X, Fan Y, Shen Y, Shi Q, Wang Q, Cui L, Yin X, Ma G. Ge Y, et al. J Cancer Res Clin Oncol. 2023 Jun;149(6):2301-2310. doi: 10.1007/s00432-022-04380-9. Epub 2022 Oct 5. J Cancer Res Clin Oncol. 2023. PMID: 36198834

7

Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?

Parikh ND, Tayob N, Singal AG. Parikh ND, et al. J Hepatol. 2023 Jan;78(1):207-216. doi: 10.1016/j.jhep.2022.08.036. Epub 2022 Sep 8. J Hepatol. 2023. PMID: 36089157 Free PMC article. Review.

8

How Much Information Do Icelandic Men Receive on Pros and Cons of Prostate-Specific Antigen Testing Prior to Undergoing Testing?

Eiriksdottir VK, Baldursdottir B, Fridriksson JO, Valdimarsdottir HB. Eiriksdottir VK, et al. Am J Mens Health. 2022 May-Jun;16(3):15579883221097805. doi: 10.1177/15579883221097805. Am J Mens Health. 2022. PMID: 35608380 Free PMC article.

9

Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer.

You CP, Leung MH, Tsang WC, Khoo US, Tsoi H. You CP, et al. Biomolecules. 2022 Jan 4;12(1):72. doi: 10.3390/biom12010072. Biomolecules. 2022. PMID: 35053220 Free PMC article. Review.

10

Locus-Specific Methylation of GSTP1, RNF219, and KIAA1539 Genes with Single Molecule Resolution in Cell-Free DNA from Healthy Donors and Prostate Tumor Patients: Application in Diagnostics.

Bryzgunova O, Bondar A, Ruzankin P, Laktionov P, Tarasenko A, Kurilshikov A, Epifanov R, Zaripov M, Kabilov M, Laktionov P. Bryzgunova O, et al. Cancers (Basel). 2021 Dec 12;13(24):6234. doi: 10.3390/cancers13246234. Cancers (Basel). 2021. PMID: 34944854 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year